Fenoldopam: Difference between revisions

Jump to navigation Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
No edit summary
Line 1: Line 1:
{{drugbox
| IUPAC_name = 8-chloro-2-(4-hydroxyphenyl)- 4-azabicyclo[5.4.0] undeca-7,9,11-triene-9,10-diol
| image = Fenoldopam.png
| CAS_number = 67227-57-0
| ATC_prefix = C01
| ATC_suffix = CA19
| ATC_supplemental =
| PubChem = 3341
| DrugBank = APRD00969
| C = 16 | H = 16 | Cl = 1 | N = 1 | O = 3
| molecular_weight = 305.756 g/mol
| bioavailability = n/a
| protein_bound =
| metabolism = [[Liver|Hepatic]] ([[Cytochrome P450 oxidase|CYP]] not involved)
| elimination_half-life = 5 minutes
| excretion = [[Kidney|Renal]] (90%) and fecal (10%)
| licence_US = Fenoldopam
| pregnancy_US = B
| legal_status =
| routes_of_administration = [[Intravenous therapy|Intravenous]]
}}
__NOTOC__
__NOTOC__
{{CMG}}
{{XXXXX}}
{{CMG}}; {{AE}}


'''''For patient information about XXXXX, click [[XXXXX (patient information)|here]].'''''


{{SB}}


==Overview==
==Overview==
'''Fenoldopam''' is a synthetic compound that acts as a selective peripheral [[Dopamine receptor|dopamine D<sub>1A</sub> receptor]] [[agonist]]. Fenoldopam is used as an antihypertensive agent. It lowers [[blood pressure]] through arteriolar [[vasodilation]], decreasing [[afterload]] and also through specific dopamine receptors along the [[nephron]] promoting [[sodium]] excretion.


{{Dopamine agonists}}
==Category==
{{Adrenergic and dopaminergic agents}}


[[Category:Benzazepines]]
==FDA Package Insert==
[[Category:Pharmacology]]
 
====Label Title====
 
'''  [[XXXXX indications and usage|Indications and Usage]]'''
'''| [[XXXXX dosage and administration|Dosage and Administration]]'''
'''| [[XXXXX dosage forms and strengths|Dosage Forms and Strengths]]'''
'''| [[XXXXX contraindications|Contraindications]]'''
'''| [[XXXXX warnings and precautions|Warnings and Precautions]]'''
'''| [[XXXXX adverse reactions|Adverse Reactions]]'''
'''| [[XXXXX drug interactions|Drug Interactions]]'''
'''| [[XXXXX use in specific populations|Use in Specific Populations]]'''
'''| [[XXXXX overdosage|Overdosage]]'''
'''| [[XXXXX description|Description]]'''
'''| [[XXXXX clinical pharmacology|Clinical Pharmacology]]'''
'''| [[XXXXX nonclinical toxicology|Nonclinical Toxicology]]'''
'''| [[XXXXX clinical studies|Clinical Studies]]'''
'''| [[XXXXX how supplied storage and handling|How Supplied/Storage and Handling]]'''
'''| [[XXXXX patient counseling information|Patient Counseling Information]]'''
'''| [[XXXXX labels and packages|Labels and Packages]]'''
 
==Mechanism of Action==
 
==References==
 
{{Reflist|2}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 23:03, 26 February 2014